CID 16131964

Hiv-1 12-mer tar rna containing 2'-o-methyl and 2',4'-locked nucleotides: 5'-[2'-ome(u)-lna(c)-2'-ome(u)-lna(c)-2'-ome(c)-lna(c)-2'-ome(a)-2'-ome(g)-2'-ome(g)-lna(c)-2'-ome(u)-2'-ome(a)-l-homoserine-6-carboxyfluorescein]

Structural Information

Molecular Formula
C153H185N43O93P12
SMILES
CC1=CN(C(=O)N=C1N)C2C3C(C(O2)(CO3)COP(=O)(O)OC4C(OC(C4OC)N5C=CC(=O)NC5=O)CO)OP(=O)(O)OCC6C(C(C(O6)N7C=CC(=O)NC7=O)OC)OP(=O)(O)OCC89COC(C8OP(=O)(O)OCC1C(C(C(O1)N1C=CC(=NC1=O)N)OC)OP(=O)(O)OCC12COC(C1OP(=O)(O)OCC1C(C(C(O1)N1C=NC3=C(N=CN=C31)N)OC)OP(=O)(O)OCC1C(C(C(O1)N1C=NC3=C1N=C(NC3=O)N)OC)OP(=O)(O)OCC1C(C(C(O1)N1C=NC3=C1N=C(NC3=O)N)OC)OP(=O)(O)OCC13COC(C1OP(=O)(O)OCC1C(C(C(O1)N1C=CC(=O)NC1=O)OC)OP(=O)(O)OCC1C(C(C(O1)N1C=NC4=C(N=CN=C41)N)OC)OP(=O)(O)OCC[C@@H](C(=O)N)NC(=O)C1=CC4=C(C=C1)C(=O)OC41C4=C(C=C(C=C4)O)OC4=C1C=CC(=C4)O)C(O3)N1C=C(C(=NC1=O)N)C)C(O2)N1C=C(C(=NC1=O)N)C)C(O9)N1C=C(C(=NC1=O)N)C
InChI
InChI=1S/C153H185N43O93P12/c1-58-32-189(145(212)177-112(58)155)134-104-108(149(273-134,44-248-104)48-260-298(232,233)278-88-72(36-197)265-126(96(88)240-5)186-25-20-81(200)174-142(186)209)286-296(228,229)258-42-75-91(99(243-8)129(268-75)188-27-22-83(202)176-144(188)211)284-300(236,237)262-50-150-45-249-105(135(274-150)190-33-59(2)113(156)178-146(190)213)109(150)288-295(226,227)257-41-74-90(98(242-7)127(266-74)185-24-19-80(154)173-141(185)208)283-299(234,235)261-49-151-46-250-107(137(275-151)192-35-61(4)115(158)180-148(192)215)111(151)289-297(230,231)259-43-79-93(101(245-10)131(270-79)194-55-169-85-117(160)165-53-167-120(85)194)281-292(220,221)254-38-77-94(102(246-11)132(271-77)195-56-170-86-121(195)181-139(162)183-124(86)205)282-293(222,223)255-39-78-95(103(247-12)133(272-78)196-57-171-87-122(196)182-140(163)184-125(87)206)285-301(238,239)263-51-152-47-251-106(136(276-152)191-34-60(3)114(157)179-147(191)214)110(152)287-294(224,225)256-40-73-89(97(241-6)128(267-73)187-26-21-82(201)175-143(187)210)280-291(218,219)253-37-76-92(100(244-9)130(269-76)193-54-168-84-116(159)164-52-166-119(84)193)279-290(216,217)252-28-23-69(118(161)203)172-123(204)62-13-16-65-68(29-62)153(277-138(65)207)66-17-14-63(198)30-70(66)264-71-31-64(199)15-18-67(71)153/h13-22,24-27,29-35,52-57,69,72-79,88-111,126-137,197-199H,23,28,36-51H2,1-12H3,(H2,161,203)(H,172,204)(H,216,217)(H,218,219)(H,220,221)(H,222,223)(H,224,225)(H,226,227)(H,228,229)(H,230,231)(H,232,233)(H,234,235)(H,236,237)(H,238,239)(H2,154,173,208)(H2,155,177,212)(H2,156,178,213)(H2,157,179,214)(H2,158,180,215)(H2,159,164,166)(H2,160,165,167)(H,174,200,209)(H,175,201,210)(H,176,202,211)(H3,162,181,183,205)(H3,163,182,184,206)/t69-,72?,73?,74?,75?,76?,77?,78?,79?,88?,89?,90?,91?,92?,93?,94?,95?,96?,97?,98?,99?,100?,101?,102?,103?,104?,105?,106?,107?,108?,109?,110?,111?,126?,127?,128?,129?,130?,131?,132?,133?,134?,135?,136?,137?,149?,150?,151?,152?/m0/s1
InChIKey
IOVVGXRUVBBMAL-SEKTYSLLSA-N
Compound name
[7-[[3-[[7-[[3-[[7-[[3-[[3-[[3-[[7-[[3-[[3-[[(3S)-4-amino-3-[(3',6'-dihydroxy-1-oxospiro[2-benzofuran-3,9'-xanthene]-5-carbonyl)amino]-4-oxobutoxy]-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(2,4-dioxopyrimidin-1-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-3-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-hydroxyphosphoryl]oxy-5-(2-amino-6-oxo-1H-purin-9-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(2-amino-6-oxo-1H-purin-9-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-3-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-3-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methoxy-hydroxyphosphoryl]oxy-5-(2,4-dioxopyrimidin-1-yl)-4-methoxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-3-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-2,5-dioxabicyclo[2.2.1]heptan-1-yl]methyl [5-(2,4-dioxopyrimidin-1-yl)-2-(hydroxymethyl)-4-methoxyoxolan-3-yl] hydrogen phosphate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

4483.792 Da
Monoisotopic Mass

-29.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 4484.7993 312.7
[M+Na]+ 4506.7812 313.0
[M-H]- 4482.7847 312.8
[M+NH4]+ 4501.8258 312.8
[M+K]+ 4522.7552 312.7
[M+H-H2O]+ 4466.7893 312.4
[M+HCOO]- 4528.7902 312.7
[M+CH3COO]- 4542.8059 312.7
[M+Na-2H]- 4504.7667 313.1
[M]+ 4483.7915 312.9
[M]- 4483.7925 312.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

No patent data available for this compound.